Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ondansetron against metoclopramide/dexamethasone--a comparative study

A K Lim1, M R Haron, T M Yap

  • 1Institute of Radiotherapy and Oncology, Hospital Kuala Lumpur.

The Medical Journal of Malaysia
|September 1, 1994
PubMed
Summary

Ondansetron significantly improved control of chemotherapy-induced nausea and vomiting compared to metoclopramide with dexamethasone. This finding highlights ondansetron

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical translation of [<sup>18</sup>F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer.

European journal of nuclear medicine and molecular imaging·2018
Same author

Cross-sectional imaging of the metal-on-metal hip prosthesis: the London ultrasound protocol.

Clinical radiology·2013
Same author

Provision of a "same-day" ultrasound service in an inner-city NHS trust: report on experience and lessons learned after the first 2 years.

Clinical radiology·2010
Same author

Changes in cellular immunity during chemotherapy for primary breast cancer with anthracycline regimens.

Journal of chemotherapy (Florence, Italy)·2008
Same author

Radiology of gestational trophoblastic neoplasia.

Clinical radiology·2006
Same author

Symptomatic lumbar synovial cyst: management with direct CT-guided puncture and steroid injection.

Clinical radiology·2002

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Medicine

Background:

  • Chemotherapy, particularly cisplatinum regimens, frequently causes severe nausea and vomiting.
  • Effective anti-emetic prophylaxis is crucial for patient tolerance and treatment adherence.

Purpose of the Study:

  • To compare the efficacy of ondansetron with metoclopramide plus dexamethasone in preventing nausea and vomiting induced by cisplatinum-based chemotherapy.

Main Methods:

  • A randomized trial involving 52 patients receiving cisplatinum chemotherapy.
  • Group 1 (34 patients) received ondansetron; Group 2 (18 patients) received metoclopramide with dexamethasone.
  • Treatment response was categorized based on the number of emetic episodes and need for rescue medication.

Main Results:

  • Complete or major control (0-2 emetic episodes) was achieved in 68% of the ondansetron group versus 17% of the metoclopramide group on day 1 (p < 0.002).
  • Nausea control was also significantly better with ondansetron (p < 0.0009).
  • A trend favoring ondansetron was observed from days 2 to 6; both treatments were well tolerated.

Conclusions:

  • Ondansetron demonstrates superior efficacy over metoclopramide with dexamethasone for prophylaxis of cisplatinum-induced nausea and vomiting.
  • Ondansetron represents a more effective option for managing chemotherapy-induced side effects.

Related Experiment Videos